[O-44] Oral Session 44

[O-44-2] Evaluation of the Long-Term Safety and Efficacy of Efgartigimod in Japanese Patients With gMG

^○Masayuki Masuda¹, Hiroyuki Murai², Yasushi Suzuki³, Shingo Konno⁴, Makoto Samukawa⁵, Takamichi Sugimoto⁶, Daisuke Yamamoto⁷, Antonio Guglietta⁸, Peter Ulrichts⁸, T'joen Caroline⁸, Tomihiro Imai⁹, Masanori Takahashi¹⁰, Akiyuki Uzawa¹¹, Kimiaki Utsugisawa¹² (1.Department of Neurology, Tokyo Medical University, Japan, 2.Department of Neurology, Osaka University Hospital, Suita, Japan, 3.Department of Neurology Graduate School of Medicine, Chiba University, Chiba, Japan, 4.Department of Neurology, Hanamaki General Hospital, 5.Department of Neurology, School of Medicine, International University of Health and Welfare, Tokyo, Japan, 6.Department of Neurology, National Hospital Organization Sendai Medical Center, 7.Department of Neurology, Toho University Ohashi Hospital Medical Center, 8.Department of Medicine, Kindai University Hospital, 9.Department of Clinical Neuroscience and Therapeutics, Hiroshima University, 10.Department of Neurology, Sapporo Medical University Hospital, Sapporo, Japan, 11.argenx, 12.Department of Neurology, National Hospital Organization Hakone Hospital)